NCT02460705View on ClinicalTrials.gov

Fecal Microbiota Transplant for Inflammatory Bowel Disease

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 20, 2016

Study Completion Date

November 4, 2017

Conditions
Inflammatory Bowel Disease
Interventions
DRUG

Biologically active human fecal material, OpenBiome

Fecal microbiota transplant

Trial Locations (1)

94143

UCSF Division of Gastroenterology at Mount Zion, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02460705 - Fecal Microbiota Transplant for Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter